
Zerosita M1000 is a prescription oral antidiabetic medicine. It is used for the management of Type 2 Diabetes Mellitus in adults. It combines two well established medicines. These are Sitagliptin and Metformin Hydrochloride (Sustained Release). The medicine helps achieve better glycemic control when diet alone isn’t enough.
Composition: Sitagliptin 50mg + Metformin HCL SR 1000mg Tablet
Sitagliptin belongs to the DPP-4 inhibitor class. It works by increasing the insulin release and decreasing the glucagon levels in the blood. All of that is done in a a glucose dependent manner. Metformin HCL SRimproves insulin sensitivity. It also reduces glucose production in the liver as well as lowers the intestinal absorption of glucose. The sustained release formulation helps maintain bloog sugar control throughout the day.
Some patients experience side effects like:
There are also some rare but serious side effects, which include lactic acidosis or pancreatitis. Make sure to seek help if you notice any unusual symptoms happening.
A – Zerosita M1000 is used to manage blood sugar levels in adults with Type 2 Diabetes Mellitus.
A – The medicine has a low risk of hypoglycemia if you use it alone. But if you use it with insulin or sulfonylureas, the risk goes up.
A – Yes, that is if you take it as prescribed and with regular medical monitoring.
A – Yes, it is mostly prescribed for daily use as advised by a doctor.
A – Metformin may help prevent weight gain. Zerosita M1000 is not a weight-loss medicine.